Lower Dose Lenalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma Who Are Aged 60 Years or over and/or at Risk of Myelosuppression: Final Analysis of the Revlite Trial and Matched Comparison to the MM009 and MM010 Trials

Authors: Hang Quach Harrison, Simon Fernyhough, Liam J. Henderson, Ross Alistair Corbett, Gillian Browett, Peter Blacklock, Hilary Anne Underhill, Craig Cannell, Paul Trotman, Judith and Link, Emma Cowan, Linda Li, Jack S. Dimopoulos, Meletios A. Prince, H. Miles
Publication date: 1 January 2015
Publisher

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens

redirect

oai

oai:lib.uoa.gr:uoadl:3168028

Last time updated on 10/02/2023